Cite
HARVARD Citation
Lin, C. et al. (2023). Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma. Cancer investigation. pp. 253-262. [Online].